{"id":"yy-162","safety":{"commonSideEffects":[{"rate":"null","effect":"Increased risk of genital yeast infections"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting SGLT2, YY-162 reduces glucose reabsorption in the kidneys, leading to decreased blood glucose levels. This makes it a potential treatment for type 2 diabetes.","oneSentence":"YY-162 is a small molecule that targets the SGLT2 receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:41:14.343Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT01201187","phase":"PHASE3","title":"Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract(YY-162)in Children With ADHD","status":"COMPLETED","sponsor":"Yuyu Pharma, Inc.","startDate":"2010-03","conditions":"Mental Disorders","enrollment":144},{"nctId":"NCT01536210","phase":"PHASE3","title":"Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract in Children With ADHD(Attention Deficit Hyperactivity Disorder)","status":"COMPLETED","sponsor":"Yuyu Pharma, Inc.","startDate":"2011-12","conditions":"Mental Disorders","enrollment":144}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Combination of Ginkgo extract and Ginseng extract","combination of Ginkgo extract and Ginseng extract"],"phase":"phase_3","status":"active","brandName":"YY-162","genericName":"YY-162","companyName":"Yuyu Pharma, Inc.","companyId":"yuyu-pharma-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"YY-162 is a small molecule that targets the SGLT2 receptor. Used for Type 2 diabetes.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}